KRYSTAL LOWRY: Open Payments
NPI 1700350451 · GREENVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$960 in 53 payments from 17 companies in 2025. Trend: 2023 $375 · 2024 $376 · 2025 $960
Food & beverage: $960
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 14 | $265 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $154 |
| Amgen Inc. | 5 | $91 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| ABBVIE INC. | 3 | $49 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| ABIOMED | 1 | $43 |
| PFIZER INC. | 2 | $35 |
Products named: Auvelity, CAPLYTA, EVENITY, VRAYLAR, FANAPT, XIFAXAN, GEMTESA, FARXIGA.
Industry payments across TX — which companies pay providers there.
